[C:1]1([CH3:20])[CH:6]=[CH:5][C:4]([CH2:7][CH2:8][S:9]([N:12]2[CH2:17][CH2:16][CH:15]([CH2:18][NH2:19])[CH2:14][CH2:13]2)(=[O:11])=[O:10])=[CH:3][CH:2]=1.C(OC([NH:28][C:29]1[N:34]=[CH:33][C:32]([C:35](O)=[O:36])=[CH:31][N:30]=1)=O)(C)(C)C.Cl>O1CCOCC1>[C:1]1([CH3:20])[CH:2]=[CH:3][C:4]([CH2:7][CH2:8][S:9]([N:12]2[CH2:17][CH2:16][CH:15]([CH2:18][NH:19][C:35]([C:32]3[CH:31]=[N:30][C:29]([NH2:28])=[N:34][CH:33]=3)=[O:36])[CH2:14][CH2:13]2)(=[O:10])=[O:11])=[CH:5][CH:6]=1The title compound was prepared from C-[1-(2-p-tolyl-ethanesulfonyl)-piperidin-4-yl]-methylamine and 2-tert-butoxycarbonylamino-pyrimidine-5-carboxylic acid, followed by treatment with 4N HCl in dioxane as described in EXAMPLE 192.
불러오는 중…